Short answer
Boston Scientific (BSX) filed an 8-K current report with the SEC on February 26, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 1.02 (Termination of a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation). BSX arranged $11B total acquisition financing: $3B 5-year revolver (matures 2031), $2B 364-day revolver, and $6B 364-day delayed-draw term loan.
Boston Scientific 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- BSX arranged $11B total acquisition financing: $3B 5-year revolver (matures 2031), $2B 364-day revolver, and $6B 364-day delayed-draw term loan
- All three facilities tied to Penumbra (PEN) acquisition announced Jan 14, 2026; term loan tranches ($1B + $5B) drawable only at deal closing
- $5B Tranche B requires mandatory repayment from any subsequent equity or debt issuance: signals BSX will likely tap capital markets post-close to refinance bridge
- Leverage covenant set at 3.75x normally, stepping up to 4.75x post-close of any acquisition >$1B debt financed, then stepping down quarterly: confirms deal will significantly stretch BSX's balance sheet
- Cash litigation payments excluded from EBITDA capped at $1.16B since Dec 31, 2025: limits covenant relief from legal settlements
Item 1.02 · Termination of a Material Definitive Agreement
- Terminated 2021 Revolving Credit Agreement (Wells Fargo as agent) on Feb 26, 2026, replaced by new 2026 facility
- Prior agreement had been amended 3 times since May 2021 inception, signaling active liability management
- Termination concurrent with new credit agreement: no gap in liquidity access for BSX
Item 2.03 · Creation of a Direct Financial Obligation
- BSX entered into 2026 Credit Agreements: full terms/details referenced from a prior section of the same filing
- Item 2.03 flags a material new financial obligation, indicating new debt or credit facility commitments by BSX
- Investors should review the complete filing for interest rate, maturity, borrowing capacity, and covenant details
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Boston Scientific 8-K filings
Get the next BSX 8-K as it lands
Follow BSX for push alerts, or ask the research agent what this filing means.